Article Text

Download PDFPDF
Maintenance treatment with olanzapine reduces relapse in people with bipolar I disorder who have responded to acute olanzapine treatment

Statistics from Altmetric.com

Footnotes

  • For correspondence: Dr M Tohen, Lilly Research Laboratories, Indianapolis, IN 46285, USA; m.tohen{at}lilly.com

  • Source of funding: Lilly Research Laboratories, USA.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.